-
公开(公告)号:US4918172A
公开(公告)日:1990-04-17
申请号:US252636
申请日:1988-10-03
申请人: Akihiro Yoshimoto , Osamu Jodo , Yoshio Watanabe , Rokuro Okamoto , Tomoyuki Ishikura , Hiroshi Naganawa , Tsutomu Sawa , Tomio Takeuchi
发明人: Akihiro Yoshimoto , Osamu Jodo , Yoshio Watanabe , Rokuro Okamoto , Tomoyuki Ishikura , Hiroshi Naganawa , Tsutomu Sawa , Tomio Takeuchi
IPC分类号: C07H15/252
CPC分类号: C07H15/252
摘要: Disclosed are anthracycline antibiotics of a formula (I): ##STR1## in which R.sup.1 and R.sup.2 are hydroxyl groups, R.sup.3 is ethyl group, R.sup.4 is methoxycarbonyl group and X represents daunosamine-rhodenose or daunosamine-deoxyfucose; orR.sup.1 and R.sup.2 are hydroxyl groups, R.sup.3 is 1-hydroxyethyl group, R.sup.4 is hydrogen atom and X represents daunosamine-rhodenose or daunosamine-deoxyfucose; orR.sup.1, R.sup.2 and R.sup.4 are hydroxyl groups, R.sup.3 is ethyl group and X represents daunosamine-rhodenose, daunosamine-deoxyfucose, rhodosamine-rhodenose, N-monomethyldaunosamine-rhodenose or N-monomethyldaunosamine-deoxyfucose; orR.sup.1 is methoxy group, R.sup.2 is hydroxyl group, R.sup.3 is ethyl group, R.sup.4 is methoxycarbonyl group and X represents daunosamine-rhodenose or daunosamine-deoxyfucose; orR.sup.1 and R.sup.4 are hydroxy groups, R.sup.2 is hydrogen atom, R.sup.3 is ethyl group and X represents daunosamine-deoxyfucose, as well as pharmaceutically acceptable acid addition salts thereof. The antibiotics (I) have a carcinostatic activity and are useful as a carcinostatic for murine leukemia L1210 cells in culture.
-
公开(公告)号:US4734493A
公开(公告)日:1988-03-29
申请号:US849229
申请日:1986-04-07
申请人: Akihiro Yoshimoto , Osamu Jodo , Yoshio Watanabe , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa
发明人: Akihiro Yoshimoto , Osamu Jodo , Yoshio Watanabe , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/704 , A61P31/04 , A61P35/00 , C07H15/252 , C12P19/56 , C12R1/465 , C07H15/24
CPC分类号: C07H15/252
摘要: The antibiotics designated obelmycins exhibit high proliferation inhibiting action against leukemia cells and are effective as anti-cancer agents.
摘要翻译: 称为替米yc嗪的抗生素对白血病细胞表现出高增殖抑制作用,作为抗癌剂是有效的。
-
公开(公告)号:US4897470A
公开(公告)日:1990-01-30
申请号:US34879
申请日:1987-04-06
申请人: Akihiro Yoshimoto , Osamu Jodo , Yoshio Watanabe , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa, deceased
发明人: Akihiro Yoshimoto , Osamu Jodo , Yoshio Watanabe , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa, deceased
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/704 , A61P35/00 , C07H15/252 , C12P29/00 , C12R1/465
CPC分类号: C07H15/252
摘要: New anthracycline antibiotics of a formula (I) are provided, which are usable as an anticancer agent ##STR1## (where R represents a hydrogen atom or a hydroxyl group). The antibiotics (I) can be produced by incubation of a dye-nonproductive or hardly dye-productive mutant strain which has an ability of converting .alpha.-citromycinone or .beta.-isorhodomycinone into the antibiotics (I), in the presence of .alpha.-citromycinone or .beta.-isorhodomycinone in a pertinent nutrient medium.
-
公开(公告)号:US4612372A
公开(公告)日:1986-09-16
申请号:US754568
申请日:1985-07-12
申请人: Takeo Yoshioka , Miharu Maeda , Rokuro Okamoto , Yasutaka Shimauchi , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa
发明人: Takeo Yoshioka , Miharu Maeda , Rokuro Okamoto , Yasutaka Shimauchi , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa
IPC分类号: C07H17/08
CPC分类号: C07H17/08
摘要: Novel tylosin derivatives are represented by formula: ##STR1## wherein R represents a hydrogen atom, an acetyl group or a propionyl group; X represents a group --CO-- or --SO.sub.2 --; Y represents a fluorine atom, an acetyl group, a methanesulfonyl group, a methylthio group, a benzoyl group or a methoxy group bound to the benzyl group at the 2-position or 4-position; and Z represents a hydrogen atom or a D-mycinose residue: ##STR2## The tylosin derivatives which are antibiotics of macrolide type provide improved antibacterial activity and improved ability of absorption and excretion in vivo.
摘要翻译: 新型泰乐菌素衍生物由下式表示:其中R代表氢原子,乙酰基或丙酰基; X表示-CO-或-SO 2 - 基团; Y表示在2位或4位与苄基结合的氟原子,乙酰基,甲磺酰基,甲硫基,苯甲酰基或甲氧基; Z代表氢原子或D-霉菌素残留物:作为大环内酯类抗生素的泰乐菌素衍生物提供了改善的抗菌活性和提高体内吸收和排泄的能力。
-
公开(公告)号:US4612371A
公开(公告)日:1986-09-16
申请号:US756876
申请日:1985-07-18
申请人: Akihiro Yoshimoto , Shizuka Fujii , Katsuro Kubo , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa
发明人: Akihiro Yoshimoto , Shizuka Fujii , Katsuro Kubo , Tomoyuki Ishikura , Tsutomu Sawa , Tomio Takeuchi , Hamao Umezawa
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/704 , A61P35/00 , C07H15/252 , C12P19/56 , C12R1/465 , C07H15/24
CPC分类号: C07H15/252
摘要: Novel anthracycline antibiotics characteristic of Ring A of the anthracycline skeleton are produced by microorganisms belonging to the genus Streptomyces and are useful as anti-cancer agents. The antibiotics designated D-788-6 to -10 are shown by general formula: ##STR1## wherein Y represents a group shown by: ##STR2##
摘要翻译: 蒽环霉素骨架A环特征的新型蒽环类抗生素由属于链霉菌属的微生物产生,可用作抗癌剂。 称为D-788-6至-10的抗生素由以下通式表示:其中Y代表如下所示的基团:
-
公开(公告)号:US4463171A
公开(公告)日:1984-07-31
申请号:US502480
申请日:1983-06-09
申请人: Hamao Umezawa , Tomio Takeuchi , Kuniaki Tatsuta , Tomoyuki Ishikura , Rokuro Okamoto , Masao Yamamoto , Kohki Kiyoshima
发明人: Hamao Umezawa , Tomio Takeuchi , Kuniaki Tatsuta , Tomoyuki Ishikura , Rokuro Okamoto , Masao Yamamoto , Kohki Kiyoshima
IPC分类号: A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08
CPC分类号: C07H17/08
摘要: Compounds of the following general formula ##STR1## wherein R.sup.1 and R.sup.2 represent a hydrogen atom or a lower alkanoyl group;R.sup.3 represents a hydrogen atom or the group --COCH.sub.2 R.sup.5 in which R.sup.5 represents a lower alkyl group or an aryl or pyridyl group bonded through a sulfur atom;R.sup.4 represents a methyl group which may be substituted by aryl, pyridyl, pyridylthio, hydroxyl or arylthioamino, an aryl group, a nitrile group, a 5- or 6-membered heterocyclic group having 1 to 4 hetero atoms selected from nitrogen and sulfur atoms, or a tetrahydropyranyl group which may be substituted by methoxy;A represents the group --OCO--, --OSO.sub.2 --, --O-- or --S--, or A and R.sup.4, taken together, represent a halogen atom, a nitrile group or a group of the formula ##STR2## in which R.sup.6 represents two lower alkyl groups, the group ##STR3## or an alkylene group having 4 to 6 carbon atoms which may have in the chain an oxygen atom or a lower alkyl-substituted nitrogen atom; and said aryl group and heterocyclic group may optionally be substituted by a methyl, methoxy or nitro group, and when R.sup.1 represents a lower alkyl group,R.sup.3 does not represent a lower alkyl group,or their salts.These novel derivatives of macrolide antibiotics have excellent antibacterial activity.
摘要翻译: 下列通式的化合物:其中R 1和R 2表示氢原子或低级烷酰基; R3表示氢原子或基团-COCH2R5,其中R5表示低级烷基或通过硫原子键合的芳基或吡啶基; R 4表示可以被芳基,吡啶基,吡啶硫基,羟基或芳硫基氨基,芳基,腈基,具有1-4个选自氮和硫原子的杂原子的5或6元杂环基取代的甲基, 或可被甲氧基取代的四氢吡喃基; A代表基团-OCO-,-OSO 2 - , - O-或-S-,或A和R 4一起代表卤素原子,腈基或式(IMAGE)基团,其中R6代表二 低级烷基,基团
或具有4-6个碳原子的亚烷基,其可以在链中具有氧原子或低级烷基取代的氮原子; 并且所述芳基和杂环基可任选被甲基,甲氧基或硝基取代,并且当R 1表示低级烷基时,R 3不表示低级烷基或其盐。 这些大环内酯类抗生素的新型衍生物具有优良的抗菌活性。 -
公开(公告)号:US4592999A
公开(公告)日:1986-06-03
申请号:US514678
申请日:1983-07-18
申请人: Hamao Umezawa , Tomio Takeuchi , Kageaki Kouno , Tomoyuki Ishikura , Akihiro Yoshimoto , Yukio Takatsuki , Hiroyasu Tobe
发明人: Hamao Umezawa , Tomio Takeuchi , Kageaki Kouno , Tomoyuki Ishikura , Akihiro Yoshimoto , Yukio Takatsuki , Hiroyasu Tobe
IPC分类号: C12P17/06 , C07H15/252 , C12P19/56 , C12R1/465
CPC分类号: C07H15/252 , C12P19/56 , C12R1/465 , Y10S435/886
摘要: This invention is to provide a new microbial process for producing daunomycin by a mutant strain belonging to the genus Streptomyces.
摘要翻译: 本发明提供一种用于通过属于链霉菌属的突变菌株生产道诺霉素的新的微生物方法。
-
公开(公告)号:US4424342A
公开(公告)日:1984-01-03
申请号:US361175
申请日:1982-03-24
申请人: Toshikazu Oki , Akihiro Yoshimoto , Yasue Matsuzawa , Tomoyuki Ishikura , Hamao Umezawa , Tomio Takeuchi
发明人: Toshikazu Oki , Akihiro Yoshimoto , Yasue Matsuzawa , Tomoyuki Ishikura , Hamao Umezawa , Tomio Takeuchi
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/704 , A61P35/00 , C07H15/252 , C12P19/56 , C12R1/465 , C07H15/24 , A61K31/71
CPC分类号: C07H15/252 , C12P19/56 , C12R1/465
摘要: Disclosed are an antitumor compound having the chemical structure ##STR1## or its acid addition salts; and its preparation method which consists of treating a compound represented by the chemical structure ##STR2## wherein R is a COCH.sub.3 or CH(OH)CH.sub.3 group, by a streptomycetes strain or its mutants.
摘要翻译: 公开了具有化学结构(I)或其酸加成盐的抗肿瘤化合物; 及其制备方法,该方法由化学结构(IMAGE)(II)表示的化合物
-
公开(公告)号:US4439603A
公开(公告)日:1984-03-27
申请号:US436630
申请日:1982-10-25
申请人: Hamao Umezawa , Tomio Takeuchi , Tomoyuki Ishikura , Akihiro Yoshimoto , Yasue Matsuzawa , Yukio Takatsuki
发明人: Hamao Umezawa , Tomio Takeuchi , Tomoyuki Ishikura , Akihiro Yoshimoto , Yasue Matsuzawa , Yukio Takatsuki
IPC分类号: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/704 , A61P35/00 , C07H15/252 , C07H15/24
CPC分类号: C07H15/252
摘要: New anthracycline derivatives, .beta.-rhodomycinone-RDA, .beta.-rhodomycinone-RDRs and .beta.-rhodomycinone-RD having potent anticancer activities and lower toxicities and a process for the production thereof by reduction or hydrolysis of .beta.-rhodomycinone-RDC are disclosed.
摘要翻译: 公开了新的蒽环类衍生物,β-近红霉素酮-RDA,β-霉菌酮-RDR和具有较强抗癌活性和较低毒性的β-二酮霉素-RR及其通过还原或水解β-维生素D-RDC生产的方法。
-
公开(公告)号:US4474945A
公开(公告)日:1984-10-02
申请号:US405917
申请日:1982-08-06
IPC分类号: C07H15/252 , C12P19/56 , C07H17/08 , C12N1/00 , C12P19/62
CPC分类号: C07H15/252 , C12P19/56 , C12R1/465 , Y10S514/908
摘要: New anthracycline compounds, 2-hydroxyaclacinomycin B having potent antitumor activity and lower toxicity, and a process for producing 2-hydroxyaclacinomycins A, B, and N by fermentation.
摘要翻译: 新的蒽环类化合物,具有有效抗肿瘤活性和较低毒性的2-羟基阿拉伯霉素B,以及通过发酵生产2-羟基卡曲霉素A,B和N的方法。
-
-
-
-
-
-
-
-
-